510(k) K903218
K903218 is an FDA 510(k) premarket notification submitted by Abbott Laboratories for the device "IMX B12". The FDA issued a decision of Substantially Equivalent on August 23, 1990. The device falls under product code LIG (Radioassay, Intrinsic Factor Blocking Antibody), a Class II device regulated under 21 CFR 862.1810. Abbott Laboratories has at least 10 other 510(k) clearances on record.
Clearance Details
- Decision
- SESE (Substantially Equivalent)
- Decision Date
- August 23, 1990
- Date Received
- July 23, 1990
- Clearance Type
- Traditional
- Expedited Review
- No
- Third Party Review
- No
Device Classification
- Device Name
- Radioassay, Intrinsic Factor Blocking Antibody
- Device Class
- Class II
- Regulation Number
- 862.1810
- Review Panel
- CH
- Submission Type